CSI Laboratories constructs new cancer diagnostics laboratory

CSI Laboratories announced that they are expanding operations to Jupiter, Florida
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
ATLANTA—A few days ago CSI Laboratories, a national cancer diagnostics laboratory, announced that they are expanding its operations to Jupiter, Florida, to better serve pathology and oncology communities throughout the state. CSI Laboratories is currently based in Atlanta, Georgia.
 
Rapid specialty diagnostics are crucial for cancer patients, who must often wait days or sometimes weeks before they know their diagnosis, and/or can begin life-saving therapies. By expanding their state-of-the-art laboratory into south Florida, CSI Laboratories will be able to provide actionable testing results to Florida patients even faster than before.
 
Florida clients will have access to CSI’s full suite of testing services including flow cytometry, FISH, IHC, cytogenetics, and molecular diagnostics. As an added benefit, clients will also have access to CSI’s Atlanta-based team of medical experts and advanced testing technology. The Florida laboratory will also offer both global and C•TECH, tech-only, services.
 
The new laboratory will be led by Dr. Mojdeh Naghashpour—a renowned Florida pathologist and graduate of the University of Miami Miller School of Medicine. Dr. Naghashpour is board certified in anatomic and clinical pathology and hematopathology, and will serve as the Jupiter laboratory’s Medical Director and Hematopathologist. In this role, she will provide expert diagnostic and consultation services to pathologists and clinicians across the state of Florida.
 
“…CSI Laboratories remains committed to supporting pathologists and oncologists across the U.S. through our delivery of exceptional service, expedited turnaround times, and quality diagnostics,” said Ron Ghafary, Founder and President of CSI Laboratories. “The addition of an esteemed pathologist such as Dr. Mojdeh Naghashpour to the CSI Laboratories family of medical experts completes the vision we had for a one-of-a-kind Florida cancer diagnostics laboratory. We look forward to having the opportunity to better serve Florida communities in need of quality cancer diagnostics.”
 
Construction of the new laboratory, located at 2141 South Alternate A1A Highway, began in February and is expected to be completed by June 2018 with daily operations beginning in July 2018.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Image Alt Text	A laboratorian wearing blue gloves places a PCR sample into a real-time PCR thermocycler, the model shown is blue and white with a large digital screen.
From primer design to sample preparation, explore comprehensive strategies to optimize PCR throughput and reproducibility.
Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue